SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

18 May 2022 Evaluate
The company witnessed a 16.80% growth in the revenue at Rs. 9128.48 millions for the quarter ended March 2022 as compared to Rs. 7815.51 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 1292.44  millions from Rs. 1422.53 millions ,decline by -9.14%.The company reported a degrowth in operating Profit to 2102.48 millions from 2259.76 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 9128.48 7815.51 16.80 32384.37 31349.82 3.30 32384.37 31349.82 3.30
Other Income 42.79 30.61 39.79 175.10 137.23 27.60 175.10 137.23 27.60
PBIDT 2102.48 2259.76 -6.96 6621.59 8750.96 -24.33 6621.59 8750.96 -24.33
Interest 40.01 57.53 -30.45 163.52 237.74 -31.22 163.52 237.74 -31.22
PBDT 2062.47 2202.23 -6.35 6458.07 8513.22 -24.14 6458.07 8513.22 -24.14
Depreciation 316.83 305.11 3.84 1261.61 1184.51 6.51 1261.61 1184.51 6.51
PBT 1745.64 1897.12 -7.98 5196.46 7328.71 -29.09 5196.46 7328.71 -29.09
TAX 453.20 474.59 -4.51 1331.31 1800.87 -26.07 1331.31 1800.87 -26.07
Deferred Tax 11.44 6.46 77.09 -3.76 -169.74 -97.78 -3.76 -169.74 -97.78
PAT 1292.44 1422.53 -9.14 3865.15 5527.84 -30.08 3865.15 5527.84 -30.08
Equity 248.01 247.68 0.13 248.01 247.68 0.13 248.01 247.68 0.13
PBIDTM(%) 23.03 28.91 -20.34 20.45 27.91 -26.75 20.45 27.91 -26.75

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×